Biosimilars Could Save $54 Billion Over the Next Decade
With a growing number of biologic drugs approaching patent expiration, pharmaceutical manufacturers are looking to develop biosimilars for these medications. Industry experts have said that emerging biosimilars can reduce drug spending, while increasing patient access to effective therapy.
